Neisseria adhesin A variation and revised nomenclature scheme

Clinical and Vaccine Immunology

Volumn 21, Issue 7, 2014, Pages 966-971

  Bambini, Stefania ^a   De Chiara, Matteo ^a   Muzzi, Alessandro ^a   Mora, Marirosa ^a   Lucidarme, Jay ^b   Brehony, Carina ^c   Borrow, Ray ^b   Masignani, Vega ^a   Comanducci, Maurizio ^a,d   Maiden, Martin C J ^c   Rappuoli, Rino ^a   Pizza, Mariagrazia ^a   Jolley, Keith A ^c  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4CMENB VACCINE; ADHESIN; BACTERIAL ANTIGEN; MENINGOCOCCUS VACCINE; NADA PROTEIN, NEISSERIA MENINGITIDIS;

AMINO ACID SEQUENCE; BACTERIUM ADHERENCE; CLASSIFICATION; DNA SEQUENCE; GENETIC VARIATION; GENETICS; HUMAN; IMMUNOLOGY; MENINGITIS, MENINGOCOCCAL; MOLECULAR GENETICS; NEISSERIA MENINGITIDIS; NUCLEOTIDE SEQUENCE; PATHOGENICITY;

ADHESINS, BACTERIAL; AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; BASE SEQUENCE; GENETIC VARIATION; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS, SEROGROUP B; SEQUENCE ANALYSIS, DNA;

EID: 84904503796     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00825-13     Document Type: Article

References (38)

1. Capecchi B, Adu-Bobie J, Di Marcello F, Ciucchi L, Masignani V, Taddei A, Rappuoli R, Pizza M, Arico B. 2005. Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells. Mol. Microbiol. 55:687-698. http://dx.doi.org/10.1111/j.1365- 2958.2004.04423.x. (Pubitemid 40203686)
2. Franzoso S, Mazzon C, Sztukowska M, Cecchini P, Kasic T, Capecchi B, Tavano R, Papini E. 2008. Human monocytes/macrophages are a target of Neisseria meningitidis adhesin A (NadA). J. Leukoc. Biol. 83:1100-1110. http://dx.doi.org/10.1189/jlb.1207810. (Pubitemid 351960341)
3. Tavano R, Franzoso S, Cecchini P, Cartocci E, Oriente F, Arico B, Papini E. 2009. The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA-OMVs, without further stimulating their proinflammatory activity on circulating monocytes. J. Leukoc. Biol. 86:143-153. http://dx.doi.org/10.1189/ jlb.0109030.
4. Mazzon C, Baldani-Guerra B, Cecchini P, Kasic T, Viola A, de Bernard M, Arico B, Gerosa F, Papini E. 2007. IFN-gamma and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A. J. Immunol. 179:3904-3916. http://dx.doi.org/10.4049/jimmunol.179.6.3904.
5. Cecchini P, Tavano R, Polverino de Laureto P, Franzoso S, Mazzon C, Montanari P, Papini E. 2011. The soluble recombinant Neisseria meningitidis adhesin NadA(Δ351-405) stimulates human monocytes by binding to extracellular Hsp90. PLoS One 6:e25089. http://dx.doi.org/10.1371/journal.pone. 0025089.
6. Montanari P, Bozza G, Capecchi B, Caproni E, Barrile R, Norais N, Capitani M, Sallese M, Cecchini P, Ciucchi L, Gao Z, Rappuoli R, Pizza M, Arico B, Merola M. 2012. Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin A (NadA)-mediated adhesion and invasion. Cell. Microbiol. 14:368-385. http://dx.doi.org/10.1111/j.1462-5822.2011.01722.x.
7. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, Neyt C, Sory MP, Stainier I. 1998. The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev. 62:1315-1352. (Pubitemid 28558301)
8. Chen D, Barniak V, VanDerMeid KR, McMichael JC. 1999. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children. Infect. Immun. 67:1310-1316. (Pubitemid 29108510)
9. Roggenkamp A, Ackermann N, Jacobi CA, Truelzsch K, Hoffmann H, Heesemann J. 2003. Molecular analysis of transport and oligomerization of the Yersinia enterocolitica adhesin YadA. J. Bacteriol. 185:3735-3744. http://dx.doi.org/10. 1128/JB.185.13.3735-3744.2003. (Pubitemid 36735923)
10. Comanducci M, Bambini S, Brunelli B, Adu-Bobie J, Arico B, Capecchi B, Giuliani MM, Masignani V, Santini L, Savino S, Granoff DM, Caugant DA, Pizza M, Rappuoli R, Mora M. 2002. NadA, a novel vaccine candidate of Neisseria meningitidis. J. Exp. Med. 195:1445-1454. http://dx.doi.org/10.1084/jem. 20020407. (Pubitemid 34602821)
11. Litt DJ, Savino S, Beddek A, Comanducci M, Sandiford C, Stevens J, Levin M, Ison C, Pizza M, Rappuoli R, Kroll JS. 2004. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease. J. Infect. Dis. 190:1488-1497. http://dx.doi.org/10.1086/424464. (Pubitemid 39332190)
12. Martin P, van de Ven T, Mouchel N, Jeffries AC, Hood DW, Moxon ER. 2003. Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation. Mol. Microbiol. 50:245-257. http://dx.doi.org/10.1046/j.1365-2958.2003.03678.x. (Pubitemid 37222801)
13. Martin P, Makepeace K, Hill SA, Hood DW, Moxon ER. 2005. Microsatellite instability regulates transcription factor binding and gene expression. Proc. Natl. Acad. Sci. U. S. A. 102:3800-3804. http://dx.doi.org/10.1073/pnas. 0406805102. (Pubitemid 40354692)
14. Metruccio MM, Pigozzi E, Roncarati D, Berlanda Scorza F, Norais N, Hill SA, Scarlato V, Delany I. 2009. A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements. PLoS Pathog. 5:e1000710. http://dx.doi.org/10.1371/ journal.ppat.1000710.
15. Fagnocchi L, Biolchi A, Ferlicca F, Boccadifuoco G, Brunelli B, Brier S, Norais N, Chiarot E, Bensi G, Kroll JS, Pizza M, Donnelly J, Giuliani MM, Delany I. 2013. Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine. Infect. Immun. 81:560-569. http://dx.doi.org/10.1128/IAI.01085-12.
16. Fagnocchi L, Pigozzi E, Scarlato V, Delany I. 2012. In the NadR regulon, adhesins and diverse meningococcal functions are regulated in response to signals in human saliva. J. Bacteriol. 194:460-474. http://dx.doi.org/10.1128/ JB.06161-11.
17. Cloward JM, Shafer WM. 2013. MtrR control of a transcriptional regulatory pathway in Neisseria meningitidis that influences expression of a gene (nadA) encoding a vaccine candidate. PLoS One 8: e56097. http://dx.doi.org/10.1371/ journal.pone.0056097.
18. Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Kugelberg E, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Tang CM, Borrow R. 2009. Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS 1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J. Clin. Microbiol. 47:3577-3585. http://dx.doi.org/10.1128/JCM.00936-09.
19. Comanducci M, Bambini S, Caugant DA, Mora M, Brunelli B, Capecchi B, Ciucchi L, Rappuoli R, Pizza M. 2004. NadA diversity and carriage in Neisseria meningitidis. Infect. Immun. 72:4217-4223. http://dx.doi.org/10.1128/IAI.72.7. 4217-4223.2004. (Pubitemid 38821936)
20. Jacobsson S, Hedberg ST, Molling P, Unemo M, Comanducci M, Rappuoli R, Olcen P. 2009. Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. Vaccine 27:1579-1584. http://dx.doi.org/10.1016/j.vaccine.2008.12.052.
21. Bambini S, Muzzi A, Olcen P, Rappuoli R, Pizza M, Comanducci M. 2009. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. Vaccine 27:2794-2803. http://dx.doi.org/10.1016/j.vaccine.2009.02.098.
22. Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, Findlow J, Ramsay ME, Kaczmarski EB, Borrow R. 2012. Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg. Infect. Dis. 18:63-70. http://dx.doi.org/10.3201/eid1801.110901.
23. Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Borrow R. 2010. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clin. Vaccine Immunol. 17:919-929. http://dx.doi.org/10.1128/CVI.00027-10.
24. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scarselli M, Storni E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E, Mason T, Tettelin H, Hood DW, Jeffries AC, Saunders NJ, Granoff DM, Venter JC, Moxon ER, Grandi G, Rappuoli R. 2000. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816-1820. http://dx.doi.org/10.1126/ science.287.5459.1816. (Pubitemid 30143965)
25. Giuliani MM, Adu-Bobie J, Comanducci M, Arico B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M. 2006. A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. U. S. A. 103:10834-10839. http://dx.doi.org/10.1073/pnas.0603940103. (Pubitemid 44148381)
26. Bambini S, Piet J, Muzzi A, Keijzers W, Comandi S, De Tora L, Pizza M, Rappuoli R, van de Beek D, van der Ende A, Comanducci M. 2013. An analysis of the sequence variability of meningococcal fHbp, NadA and NHBAover a 50-year period in the Netherlands. PLoS One 8:e65043. http://dx.doi.org/10.1371/journal. pone.0065043.
27. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
28. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Molecular biology and evolution. 24:1596-1599. http://dx.doi.org/10.1093/molbev/msm092. (Pubitemid 47236692)
29. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. 2009. Jalview Version 2 - a multiple sequence alignment editor and analysis workbench. Bioinformatics 25: 1189-1191. http://dx.doi.org/10.1093/bioinformatics/btp033.
30. Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Mol. Biol. Evol. 23:254-267. http://dx.doi.org/10.1093/ molbev/msj030. (Pubitemid 43100040)
31. Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, Gray S, Kaczmarski E. 2000. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356:2159. http://dx.doi.org/10.1016/S0140-6736(00)03502-9. (Pubitemid 32047958)
32. Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha MK, Ajello GW, Schmink SE, Noble CA, Tondella ML, Whitney AM, Al-Mazrou Y, Al-Jefri M, Mishkhis A, Sabban S, Caugant DA, Lingappa J, Rosenstein NE, Popovic T. 2002. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J. Infect. Dis. 185:1596-1605. http://dx.doi.org/10.1086/340414. (Pubitemid 34587521)
33. Taha MK, Giorgini D, Ducos-Galand M, Alonso JM. 2004. Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J. Clin. Microbiol. 42: 4158-4163. http://dx.doi.org/10.1128/JCM.42.9.4158-4163.2004. (Pubitemid 39296139)
34. Jolley KA, Maiden MC. 2010. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595. http://dx.doi.org/10.1186/1471-2105-11-595.
35. Tauseef I, Ali YM, Bayliss CD. 2013. Phase variation of PorA, a major outer membrane protein, mediates escape of bactericidal antibodies by Neisseria meningitidis. Infect. Immun. 81:1374-1380. http://dx.doi.org/10.1128/IAI.01358- 12.
36. Castilla J, Vazquez JA, Salcedo C, Garcia Cenoz M, Garcia Irure JJ, Torroba L, Beristain X, Abad R, Barricarte A. 2009. B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain. J. Clin. Microbiol. 47:463-465. http://dx.doi.org/10.1128/JCM.01495-08.
37. Muzzi A, Mora M, Pizza M, Rappuoli R, Donati C. 2013. Conservation of meningococcal antigens in the genus Neisseria. mBio 4:e00163-13. http://dx.doi.org/10.1128/mBio.00163-13.
38. Findlow J, Borrow R, Snape MD, Dawson T, Holland A, John TM, Evans A, Telford KL, Ypma E, Toneatto D, Oster P, Miller E, Pollard AJ. 2010. Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin. Infect. Dis. 51:1127-1137. http://dx.doi.org/10.1086/656741.